Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program

• Κύριοι συγγραφείς: Sean Wharton (Συγγραφέας), Christiane L Haase (Συγγραφέας), Elham Kamran (Συγγραφέας), Aiden Liu (Συγγραφέας), Johanna Mancini (Συγγραφέας), Drew Neish (Συγγραφέας), Arash Pakseresht (Συγγραφέας), G Sarah Power (Συγγραφέας), Rebecca AG Christensen (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Wiley, 2020-08-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Summary Objective Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical records of 311 patients is the first real‐world study...